Beta Drugs
BETA •NSE

Beta Drugs

₹1,655.40-108.80 (6.17%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
1,620.00
Today’s high
1,774.20
52 week low
990.10
52 week high
2,807.90
Open price
1,735.50
Previous close
1,764.20
Live volume
1,26,295
Lower circuit
1,324.40
Upper circuit
1,986.40

Fundamentals

Market Cap
₹1,962Cr
ROE
11.86%
P/E Ratio(TTM)
36.78
EPS(TTM)
47.96
P/B Ratio
4.48
Dividend Yield
0.00%
Industry P/E
40.13
Book Value
393.57
Debt to Equity
0.11
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
SEP '26
₹139Cr
+9.53%
₹19.28Cr
+16.92%
037.575112.5150
Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Revenue growthValue
1Y (TTM)+31%
3Y CAGR+20%
Profit growthValue
1Y (TTM)+58%
3Y CAGR+11%

About

Beta Drugs Limited manufactures pharmaceutical formulations, specializing in oncology products and potent drugs.;
CEO/MD
Vijay Kumar Batra
Founded in
2005
NSE symbol
BETA
Industry

Shareholding pattern

Dec '25
Mar '26
May '26
Jun '26
Sep '26
Shareholder details

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
PfizerPFIZER
₹3,856.00
+5.70 (0.15%)
L
    H
    17,611.5020.494.02
    Natco PharmaNATCOPHARM
    ₹814.30
    -7.65 (0.93%)
    L
      H
      16,115.2019.431.46
      ₹2,029.10
      -55.50 (2.66%)
      L
        H
        15,851.4822.644.06
        ₹6,167.50
        +54.50 (0.89%)
        L
          H
          15,301.1386.0917.41
          Livesquawk •
          Beta Drugs collaborates with IMGSA Groupe SPA for oncology product manufacturing in Algeria. The partnership aims to expand local production capacity and support cancer-focused supply.
          Livesquawk •
          Beta Drugs reported Q2 consolidated net profit of ₹193M, up from ₹120M year-over-year. The quarterly performance marks a strong year-over-year earnings improvement for the company.
          2026
          22
          Oct
          Quarterly Result
          Release date
          20
          Jul
          Quarterly Result
          Release date
          14
          May
          Annual Result
          Release date
          2025
          6
          Nov
          Result
          Release date

          26
          Mar
          Bonus
          Ex date
          20:1
          Ratio

          For every 20 shares you hold, you will receive 1 additional shares
          Bonus ratio1:20
          Ex date26 Mar ‘25
          Record date26 Mar ‘25
          Announcement date21 Mar ‘25

          21
          Mar
          Bonus
          Announced
          20:1
          Ratio

          For every 20 shares you hold, you will receive 1 additional shares
          Bonus ratio1:20
          Ex date26 Mar ‘25
          Record date26 Mar ‘25
          Announcement date21 Mar ‘25
          Events calendar
          View upcoming events in other stocks